SCHEMBL1114739

SCHEMBL1114739

COc1cc2c(cc1OC)C(=O)C(=Cc1cc[n+](Cc3ccccc3)cc1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7899943 1.00 ACHE (1.00) ACHE
SCHEMBL14500076 1.00 ACHE (1.00) ACHE
Bromide SCHEMBL4726271 0.99 ACHE (1.00) ACHE
SCHEMBL12306067 0.85 ACHE (0.74) ACHE
SCHEMBL8010257 0.85 ACHE (0.74) ACHE
SCHEMBL27820343 0.85 ACHE (0.74) ACHE
SCHEMBL19781956 0.84 ACHE (0.73) ACHE
SCHEMBL17321081 0.82 ACHE (0.69) ACHE
SCHEMBL17321126 0.81 ACHE (0.68) ACHE
SCHEMBL17321129 0.81 ACHE (0.67) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2278970-B1 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE CIPLA LTD (IN) 2015-04-22 — — EP disclosed
US-8987458-B2 Process for the preparation of donepezil hydrochloride CIPLA LIMITED (IN) 2015-03-24 — — US disclosed
US-20110077271-A1 Process for the Preparation of Donepezil Hydrochloride CIPLA LIMITED (IN) 2011-03-31 — — US disclosed
EP-2278970-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE Cipla Limited (IN) 2011-02-02 — — EP disclosed
WO-2009118516-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE CIPLA LIMITED (GB) 2009-10-01 — — WO disclosed
US-20090137811-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL AND INTERMEDIATE COMPOUNDS THEREOF AS WELL AS HYDRATES OF DONEPEZIL PLIVA HRVATSKA D.O.O 2009-05-28 — — US disclosed
US-20090137811-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL AND INTERMEDIATE COMPOUNDS THEREOF AS WELL AS HYDRATES OF DONEPEZIL PLIVA HRVATSKA D.O.O 2009-05-28 — — US disclosed
US-7446203-B2 Preparation of intermediates for acetycholinesterase inhibitors HETERO DRUGS LIMITED (IN) 2008-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137811-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL AND INTERMEDIATE COMPOUNDS THEREOF AS WELL AS HYDRATES OF DONEPEZIL ACHE, BCHE, WIZ ACHE 1/4885
US-20110077271-A1 Process for the Preparation of Donepezil Hydrochloride ACHE, CHRNA5, BCHE ACHE 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback